- To treat anemia in chronic kidney failure
- To treat anemia caused by chemotherapy
Darnesp 40mcg Injection
MRP | : |
|
Price | : | ₹1,500.00 |
You Save | : | ₹752.81 (33.42%) |
1 Prefilled Syringe(s)
Darnesp 40mcg injection contains Darbepoetin Alfa as its active ingredient. This antineoplastic medication falls under the category of hematopoietic growth factors. It is prescribed for treating anemia (a condition characterized by a lower than normal red blood cell count) in individuals suffering from chronic kidney disease. Additionally, it is indicated for managing anemia resulting from chemotherapy in patients with specific cancer types. Common symptoms of anemia include fatigue, weakness, and shortness of breath.
Do not use Darnesp 40mcg injection if you are allergic to Darbepoetin alfa or any of its components, and if you have uncontrolled hypertension. It is essential to inform your healthcare provider if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergies to latex or hepatitis C. Also, notify your physician if you are pregnant or nursing.
Should you experience severe headaches, dizziness, drowsiness, confusion, vision problems, nausea, vomiting, or seizures after administering Darnesp 40mcg injection, contact your physician immediately and seek medical assistance. The most frequently reported side effects of this medication include hypertension, shortness of breath, leg swelling, and coughing.